IL13 and helminthiasis: Concurrently, the ILC2INFLAM produces type 2 inflammatory cytokines IL-5 and IL-13, which recruit eosinophils and exert dual immunomodulatory effects: conferring protection against helminth infections while promoting the pathogenesis of allergic diseases (90).